Jim Sullivan is the Chief Executive Officer at Vanqua Bio, where they have advanced over 100 compounds into clinical development across various disease states and technology platforms. With experience as a Venture Partner at OrbiMed and in multiple senior roles at AbbVie, they have a strong background in R&D within the Pharmaceutical and Biotech industries. Jim also served as an adjunct professor at Northwestern University and held positions at Abbott and Nova Pharmaceuticals early in their career. They earned a Ph.D. in Biochemistry from Trinity College Dublin.
This person is not in the org chart
This person is not in any teams
This person is not in any offices